Cyclacel Pharmaceuticals Inc (CYCC) — Working Capital to Net Assets Ratio
Cyclacel Pharmaceuticals Inc (CYCC) has a Working Capital to Net Assets ratio of 99.8% as of June 2025. Working capital of $3.62K (current assets of $4.38K minus current liabilities of $760.00) is measured against net assets of $3.63K. A higher ratio indicates strong short-term liquidity financed by the equity base. See CYCC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cyclacel Pharmaceuticals Inc Working Capital to Net Assets (2003–2024)
This chart shows how Cyclacel Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2003 to 2024. As of June 2025, the ratio stands at 99.8%, reflecting working capital of $3.62K against net assets of $3.63K USD. For the complete balance sheet picture, see CYCC total assets.
Annual Working Capital to Net Assets for Cyclacel Pharmaceuticals Inc (2003–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cyclacel Pharmaceuticals Inc from 2003 to 2024, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Cyclacel Pharmaceuticals Inc (CYCC) asset resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 119.3% | $-2.59 Million | $-2.17 Million | $3.67 Million | $6.27 Million | ▲ +237.4 pp |
| 2023 | -118.1% | $-717.00K | $607.00K | $7.44 Million | $8.16 Million | ▼ -200.8 pp |
| 2022 | 82.7% | $16.90 Million | $20.43 Million | $24.41 Million | $7.51 Million | ▼ -11.5 pp |
| 2021 | 94.3% | $35.53 Million | $37.69 Million | $40.94 Million | $5.41 Million | ▼ -4.9 pp |
| 2020 | 99.2% | $32.98 Million | $33.26 Million | $35.47 Million | $2.49 Million | ▲ +0.0 pp |
| 2019 | 99.1% | $11.60 Million | $11.70 Million | $14.02 Million | $2.42 Million | ▼ -1.3 pp |
| 2018 | 100.4% | $15.34 Million | $15.27 Million | $19.79 Million | $4.45 Million | ▼ 0.0 pp |
| 2017 | 100.4% | $21.86 Million | $21.77 Million | $25.97 Million | $4.11 Million | ▼ -0.2 pp |
| 2016 | 100.6% | $14.36 Million | $14.27 Million | $19.62 Million | $5.26 Million | ▲ +0.7 pp |
| 2015 | 99.9% | $18.81 Million | $18.84 Million | $24.57 Million | $5.75 Million | ▲ +0.7 pp |
| 2014 | 99.2% | $21.51 Million | $21.69 Million | $29.00 Million | $7.49 Million | ▲ +0.4 pp |
| 2013 | 98.8% | $27.68 Million | $28.02 Million | $35.17 Million | $7.50 Million | ▲ +3.6 pp |
| 2012 | 95.2% | $9.54 Million | $10.02 Million | $18.87 Million | $9.34 Million | ▼ -4.0 pp |
| 2011 | 99.1% | $19.33 Million | $19.50 Million | $25.83 Million | $6.50 Million | ▲ +0.8 pp |
| 2010 | 98.4% | $24.52 Million | $24.92 Million | $31.05 Million | $6.54 Million | ▲ +22.0 pp |
| 2009 | 76.4% | $3.55 Million | $4.64 Million | $13.37 Million | $9.82 Million | ▼ -22.4 pp |
| 2008 | 98.8% | $20.39 Million | $20.64 Million | $29.01 Million | $8.63 Million | ▲ +14.1 pp |
| 2007 | 84.6% | $49.06 Million | $57.97 Million | $63.78 Million | $14.71 Million | ▼ -8.5 pp |
| 2006 | 93.2% | $50.24 Million | $53.92 Million | $58.16 Million | $7.92 Million | ▲ +12.3 pp |
| 2005 | 80.9% | $11.81 Million | $14.60 Million | $17.03 Million | $5.22 Million | ▼ -11.9 pp |
| 2004 | 92.8% | $40.93 Million | $44.12 Million | $48.34 Million | $7.41 Million | ▲ +91.8 pp |
| 2003 | 1.0% | $-653.00K | $-64.84 Million | $14.06 Million | $14.71 Million | — |